BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29897006)

  • 21. An autosomal dominant form of adolescent multinodular goiter.
    Couch RM; Hughes IA; DeSa DJ; Schiffrin A; Guyda H; Winter JS
    Am J Hum Genet; 1986 Dec; 39(6):811-6. PubMed ID: 3799599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of unsuspected thyroid cancer in multinodular thyroid disease.
    Karalus M; Tamatea JA; Conaglen HM; Meyer-Rochow GY; Conaglen JV; Elston MS
    N Z Med J; 2018 Jan; 131(1468):69-74. PubMed ID: 29346358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.
    Pires C; Marques IJ; Dias D; Saramago A; Leite V; Cavaco BM
    Endocrine; 2021 Sep; 73(3):588-597. PubMed ID: 33683595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
    Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
    World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and management of multinodular goiter.
    Hurley DL; Gharib H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?
    Kaliszewski K; Strutyńska-Karpińska M; Zubkiewicz-Kucharska A; Wojtczak B; Domosławski P; Balcerzak W; Łukieńczuk T; Forkasiewicz Z
    PLoS One; 2016; 11(12):e0168654. PubMed ID: 28005977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). International Consortium for the Genetics of Autoimmune Thyroid Disease.
    Tomer Y; Barbesino G; Greenberg DA; Concepcion E; Davies TF
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4321-7. PubMed ID: 9851771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
    Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
    Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral thyroidectomy for the treatment of benign multinodular goiter.
    Bauer PS; Murray S; Clark N; Pontes DS; Sippel RS; Chen H
    J Surg Res; 2013 Sep; 184(1):514-8. PubMed ID: 23688788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of DICER1 variants in large multinodular goiter: thyroid function, clinical and imaging characteristics.
    Cabral Miranda LJ; Danilovic DLS; Vanderlei FAB; Tavares MR; Neto NL; Asato de Camargo RY; Marui S
    Arch Endocrinol Metab; 2024 Feb; 68():e230030. PubMed ID: 38330293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
    Bignell GR; Canzian F; Shayeghi M; Stark M; Shugart YY; Biggs P; Mangion J; Hamoudi R; Rosenblatt J; Buu P; Sun S; Stoffer SS; Goldgar DE; Romeo G; Houlston RS; Narod SA; Stratton MR; Foulkes WD
    Am J Hum Genet; 1997 Nov; 61(5):1123-30. PubMed ID: 9345104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial multinodular goiter syndrome with papillary thyroid carcinomas: mutational analysis of the associated genes in 5 cases from 1 Chinese family.
    Liao S; Song W; Liu Y; Deng S; Liang Y; Tang Z; Huang J; Dong D; Xu G
    BMC Endocr Disord; 2013 Oct; 13():48. PubMed ID: 24144365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathyroidal lymphocytes from non toxic multinodular goiter: no evidence for production of thyroid stimulating antibodies.
    Mavilia C; Vallin E; Frediani U; Rotella CM; Toccafondi R
    Autoimmunity; 1990; 6(4):239-48. PubMed ID: 1983328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.
    Fiore E; Rago T; Scutari M; Ugolini C; Proietti A; Di Coscio G; Provenzale MA; Berti P; Grasso L; Mariotti S; Pinchera A; Vitti P
    J Endocrinol Invest; 2009 Apr; 32(4):344-51. PubMed ID: 19636204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D status in Egyptian euthyroid multinodular non-toxic goiter patients and its correlation with TSH levels.
    Aboelnaga MM; Elshafei MM; Elsayed E
    Endocrinol Nutr; 2016 Oct; 63(8):380-6. PubMed ID: 27552913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidental cancer in multinodular goitre post thyroidectomy.
    Bombil I; Bentley A; Kruger D; Luvhengo TE
    S Afr J Surg; 2014 Feb; 52(1):5-9. PubMed ID: 24881131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.
    Stępień T; Brożyna M; Kuzdak K; Motylewska E; Komorowski J; Stępień H; Ławnicka H
    Dis Markers; 2017; 2017():4962137. PubMed ID: 28255192
    [No Abstract]   [Full Text] [Related]  

  • 40. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid.
    Burgess JR; Duffield A; Wilkinson SJ; Ware R; Greenaway TM; Percival J; Hoffman L
    J Clin Endocrinol Metab; 1997 Feb; 82(2):345-8. PubMed ID: 9024215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.